Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Kritika Sarmah

Pfizer’s Q3 2025 Earnings: What to Expect

With a market cap of $139.4 billion, Pfizer Inc. (PFE) is a global biopharmaceutical company headquartered in New York, known for developing and manufacturing medicines and vaccines across areas such as oncology, immunology, and infectious diseases. Its key products include Comirnaty, Paxlovid, Eliquis, and Ibrance.

The pharma titan is slated to announce its fiscal Q3 2025 results before the market opens on Tuesday, Nov. 4. Ahead of the event, analysts predict Pfizer to report an adjusted EPS of $0.68, down 35.9% from $1.06 in the year-ago quarter. However, the company has surpassed Wall Street's bottom-line estimates in the past four quarterly reports. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.